“Pink” Urine Helps Diagnose Acute Hepatic Porphyria
https://unsplash.com/photos/z4n8CGRuzOA

“Pink” Urine Helps Diagnose Acute Hepatic Porphyria

When a 23-year-old woman, who was 6 weeks pregnant, first appeared at the doctor, she was presenting with non-specific symptoms: pale eyelids, abdominal pain, intermittent cramping, and generalized arm and…

Continue Reading “Pink” Urine Helps Diagnose Acute Hepatic Porphyria
Alnylam Pharmaceuticals Submits New Drug Application for Experimental Acute Hepatic Porphyria Drug
Aymanjed / Pixabay

Alnylam Pharmaceuticals Submits New Drug Application for Experimental Acute Hepatic Porphyria Drug

According to a press release from Alnylam Pharmaceuticals, the Massachusetts-based biopharmaceutical company has completed the submission of its New Drug Application (NDA) for givosiran — its experimental acute hepatic porphyria…

Continue Reading Alnylam Pharmaceuticals Submits New Drug Application for Experimental Acute Hepatic Porphyria Drug
Encouraging Topline Data has Been Shared From a Phase 3 Study of a Drug for Acute Hepatic Porphyria
source: pixabay.com

Encouraging Topline Data has Been Shared From a Phase 3 Study of a Drug for Acute Hepatic Porphyria

Topline results have been shared from a Phase 3 study of the investigational drug givosiran in patients with acute hepatic porphyria. For more detailed information you can view the source…

Continue Reading Encouraging Topline Data has Been Shared From a Phase 3 Study of a Drug for Acute Hepatic Porphyria
A Widely Used Antifungal Drug Could be Effective For Treating Congenital Erthropoietic Porphyria
Alexas_Fotos / Pixabay

A Widely Used Antifungal Drug Could be Effective For Treating Congenital Erthropoietic Porphyria

According to a story from Medical Xpress, an international group of scientists from the US, France, and Spain may have discovered that an antifungal agent commonly used to treat skin…

Continue Reading A Widely Used Antifungal Drug Could be Effective For Treating Congenital Erthropoietic Porphyria